Alzheimer’s Disease Treatment Market Value Predicted To Reach US$ 5,647.5 Million By 2027: Acumen Research And Consulting
07. April 2021 10:12 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Alzheimer’s Disease Treatment Market– Global Industry Analysis, Market Size,...
IGC Announces Financial Results for Fiscal Year Ended March 31, 2018
21. Juni 2018 17:38 ET
|
India Globalization Capital
BETHESDA, Md., June 21, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) announces financial results for the fiscal year ended March 31, 2018. “In fiscal 2018, the...
India Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13
12. Februar 2018 08:00 ET
|
ram mukunda
BETHESDA, Md., Feb. 12, 2018 (GLOBE NEWSWIRE) --
India Globalization Capital, Inc. (NYSE-MKT:IGC) announced today that Ram Mukunda will be a speaker at the upcoming CEO Healthcare Symposium...
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 29, 2017
18. Dezember 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Dec. 18, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), adjourned again the voting for Proposals Three and Four from its Notice of Annual Meeting of...
India Globalization Capital Provides Update on Hyalolex for Alzheimer’s Commercialization Strategy
14. Dezember 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Dec. 14, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today provides an update on corporate initiatives to launch its lead product for Alzheimer’s,...
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 15, 2017
22. November 2017 17:00 ET
|
India Globalization Capital
BETHESDA, Md., Nov. 22, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), adjourned again the voting for Proposals Three and Four from its Notice of Annual Meeting of...
India Globalization Capital Reports Second Quarter 2018 Financial Results and Operational Highlights
20. November 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Nov. 20, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), today reported financial results for the second quarter ended September 30, 2017 and provided...
India Globalization Capital Regains NYSE American Listing Compliance
10. November 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Nov. 10, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) announced that it received a letter on November 9, 2017 from NYSE Regulation stating that it is...
IGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical Dispensaries
18. Oktober 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Oct. 18, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides compelling in vitro data compiled from genetically engineered cell lines within an...
NYSE American Extends India Globalization Capital Compliance Plan Period
12. Oktober 2017 14:59 ET
|
India Globalization Capital
BETHESDA, Md., Oct. 12, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital Inc. (NYSE American:IGC) announces that on October 11, 2017 it received notice from NYSE American LLC (“the Exchange”)...